GO:0042177 negative regulation of protein catabolic process: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042177 describes any process that stops, prevents, or reduces the frequency, rate, or extent of protein catabolic process.
• It is a biological_process ontology term that includes negative regulation of protein breakdown, catabolism, and degradation.
• Key molecular players include SCF complex components, Lag2, AMPK, HSC70, and MAPK-regulated 4F2hc/Girdin, which modulate protein stability and degradation.
• Dysregulation of this process is linked to cancer, metabolic disorders, and muscle wasting under negative energy balance.
• CRISPR knockout, point mutation, knock-in, and overexpression models are essential to dissect causal roles of genes in this regulatory pathway.
• Studying GO:0042177 requires integrated methods such as proteomics, RNA-seq, and imaging to track protein turnover and signaling dynamics.
Description
The Gene Ontology term GO:0042177, negative regulation of protein catabolic process, defines any biological process that stops, prevents, or reduces the frequency, rate, or extent of protein catabolic process. Protein catabolism encompasses the breakdown of proteins into smaller peptides or amino acids, and its negative regulation is critical for maintaining protein homeostasis, controlling signal transduction, and adapting to cellular stress. Researchers study this term to understand how cells stabilize key regulatory proteins, often through post-translational modifications or interactions with E3 ubiquitin ligases and chaperones. This process is not a single pathway but a convergence point for diverse mechanisms, including inhibition of ubiquitin-proteasome system components, modulation of autophagy, and regulation of protease activity. For example, the longevity protein Lag2 interacts with the SCF complex to regulate its function, thereby influencing protein degradation. Similarly, AMPK and HSC70 regulate the stability of FSP27, a lipid droplet-associated protein, linking energy sensing to protein catabolism. These examples highlight the broad biological significance of GO:0042177. Understanding negative regulation of protein catabolic process is essential for biomedical research because its dysregulation contributes to diseases such as cancer, neurodegeneration, and metabolic disorders. Moreover, this term is frequently enriched in transcriptomic and proteomic datasets, making it a target for functional validation using CRISPR-based models. This article provides a research-grade overview of GO:0042177, integrating authoritative QuickGO data with verified PubMed literature to support experimental design and generative-AI retrieval.
negative regulation of protein catabolic process At A Glance
| GO ID | GO:0042177 |
|---|---|
| GO term | negative regulation of protein catabolic process |
| Ontology | biological_process |
| Synonym | inhibition of protein catabolic process; down-regulation of protein degradation; negative regulation of cellular protein breakdown |
| Major function | Stops, prevents, or reduces the frequency, rate, or extent of protein catabolic process. |
| Related processes | Protein homeostasis, ubiquitin-proteasome system, autophagy, signal transduction. |
| Key regulators | SCF complex, Lag2, AMPK, HSC70, MAPK-regulated 4F2hc/Girdin. |
| Disease relevance | Cancer, metabolic disorders, muscle wasting, neurodegeneration. |
| Research methods | CRISPR KO/point mutation/knock-in/overexpression, proteomics, RNA-seq, imaging. |
What Is GO:0042177?
GO:0042177, negative regulation of protein catabolic process, is defined as any process that stops, prevents, or reduces the frequency, rate, or extent of protein catabolic process. In other words, it encompasses molecular events that slow down or inhibit the breakdown of proteins, whether through the ubiquitin-proteasome system, autophagy, or other proteolytic pathways. This term is a child of negative regulation of catabolic process and is distinct from positive regulation or regulation of protein catabolic process.
Why Is negative regulation of protein catabolic process Important in Cell Biology?
Negative regulation of protein catabolic process is fundamental to cellular physiology because it controls the lifetime of regulatory proteins, thereby influencing cell cycle progression, apoptosis, and stress responses. Its dysregulation can lead to the accumulation of oncoproteins or the premature loss of tumor suppressors, contributing to cancer and other diseases. Moreover, this process is a key node in metabolic signaling, as seen in the AMPK-HSC70-mediated stabilization of FSP27. Understanding GO:0042177 is therefore critical for developing therapeutic strategies that target protein degradation pathways.
• Maintains protein homeostasis by preventing excessive breakdown of essential proteins.
• Regulates cell cycle and apoptosis through stabilization of cyclins and other regulatory proteins.
• Modulates immune signaling by controlling the stability of immune-related proteins.
• Influences metabolic adaptation by regulating lipid droplet proteins like FSP27.
• Contributes to muscle protein balance under negative energy balance.
• Is implicated in cancer progression via altered degradation of oncoproteins and tumor suppressors.
• Plays a role in neuronal survival and neurodegeneration by affecting protein aggregation.
• Serves as a target for therapeutic intervention in diseases with aberrant protein catabolism.
• Provides a mechanistic link between environmental stress and protein stability.
• Is a frequent hit in functional genomics screens, including CRISPR-based studies.
What Happens During negative regulation of protein catabolic process?
Initiation of negative regulation
In simple terms: The cell senses a need to protect certain proteins from being broken down.
Negative regulation of protein catabolic process begins when cellular signals, such as stress or growth factor withdrawal, activate pathways that inhibit proteolytic machinery. For instance, salt stress in Arabidopsis activates the CDK8-AHL10-SUVH2/9 module to dynamically regulate salt tolerance, which may involve stabilization of proteins. In mammalian cells, MAPK-regulated 4F2hc/Girdin complex negatively regulates amino acid signaling, indirectly affecting protein catabolism.
Inhibition of ubiquitin-proteasome system
In simple terms: The cell blocks the tagging and destruction of proteins by the proteasome.
A major mechanism is the inhibition of E3 ubiquitin ligases or proteasome activity. The longevity protein Lag2 interacts with the SCF complex and regulates its function, thereby modulating substrate degradation. This interaction can prevent the ubiquitination of specific targets, reducing their catabolism. Similarly, AMPK and HSC70 regulate FSP27 protein stability, likely by affecting its ubiquitination and proteasomal degradation.
Regulation of autophagy
In simple terms: The cell slows down the recycling of proteins through autophagy.
Autophagy is a major catabolic pathway, and its negative regulation contributes to GO:0042177. Although direct evidence from the provided citations is limited, the Rcs regulatory cascade in bacteria exemplifies complex negative regulation of cellular processes. In eukaryotes, mTOR signaling is a well-known inhibitor of autophagy, but specific citations here focus on other regulators.
Stabilization of target proteins
In simple terms: Specific proteins are protected from degradation, allowing them to accumulate.
Negative regulation often results in the stabilization of key proteins. For example, the Hippo pathway kinases regulate substrate stability, impacting cell proliferation and apoptosis. In skeletal muscle, negative energy balance alters protein turnover, and dietary protein can modulate these effects. The net outcome is a reduced rate of protein catabolism for selected proteins.
Feedback and crosstalk
In simple terms: The process is fine-tuned by feedback loops and interactions with other pathways.
Negative regulation of protein catabolic process is integrated with other cellular networks. The Rcs regulatory cascade in bacteria illustrates how complex phosphorelay systems can negatively regulate downstream processes. In yeast, Maf1 regulates RNA polymerase III transcription, which indirectly affects protein synthesis and catabolism. These examples highlight the interconnected nature of this regulation.
Key Genes Involved in GO:0042177 negative regulation of protein catabolic process
The following genes and proteins are experimentally validated regulators or effectors of negative regulation of protein catabolic process (GO:0042177), based on the provided literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Lag2 | Interacts with SCF complex to regulate its function | Longevity and protein degradation control |
| SCF complex components | E3 ubiquitin ligase; target of Lag2 | Central to ubiquitin-proteasome system |
| AMPK | Regulates FSP27 stability | Energy sensing and lipid metabolism |
| HSC70 | Chaperone regulating FSP27 stability | Protein folding and degradation |
| 4F2hc/Girdin | MAPK-regulated complex negatively regulates amino acid signaling | Amino acid sensing and mTOR pathway |
| CDK8 | Part of CDK8-AHL10-SUVH2/9 module in salt stress | Stress response and protein stabilization |
| AHL10 | Component of salt stress module | Transcriptional regulation |
| SUVH2/9 | Histone methyltransferases in salt stress module | Chromatin regulation |
| Maf1 | Regulates RNA polymerase III transcription | Transcription and protein synthesis |
| Rcs cascade proteins | Complex regulatory cascade in bacteria | Model for negative regulation |
| Hippo pathway kinases | Regulate substrate stability | Cell growth and apoptosis |
| FSP27 | Lipid droplet protein stabilized by AMPK/HSC70 | Metabolic disease research |
| Girdin | Scaffold protein in amino acid signaling | Cancer and metabolism |
| Cyclins | Regulatory proteins stabilized by negative regulation | Cell cycle control |
| p53 | Tumor suppressor whose stability is regulated | Cancer research |
| NF-κB | Transcription factor regulated by degradation | Inflammation and immunity |
| mTOR | Kinase that inhibits autophagy | Growth and metabolism |
How Is negative regulation of protein catabolic process Regulated?
Negative regulation of protein catabolic process is itself tightly regulated by upstream signaling pathways. For example, the CDK8-AHL10-SUVH2/9 module dynamically regulates salt tolerance in Arabidopsis, likely through phosphorylation and chromatin modification. In mammalian cells, MAPK signaling regulates the 4F2hc/Girdin complex to negatively control amino acid signaling, which can impact protein catabolism. AMPK and HSC70 coordinate to regulate FSP27 stability in response to energy status. Additionally, the Rcs regulatory cascade in bacteria exemplifies a complex phosphorelay system that negatively regulates downstream processes. These examples illustrate that negative regulation of protein catabolism is responsive to environmental and metabolic cues.
negative regulation of protein catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FSP27 | Lipid metabolism disorders | Knockout and overexpression in adipocytes |
| Girdin | Cancer and metabolic signaling | Point mutation and knockout in cell lines |
| Lag2 | Longevity and protein degradation | Overexpression in yeast or mammalian cells |
| Hippo pathway kinases | Cancer and organ size control | Knockout and knock-in in mouse models |
| AMPK | Metabolic syndrome and diabetes | Point mutation and knockout in muscle cells |
Cancer
Dysregulation of protein catabolic processes is a hallmark of cancer. Negative regulation of protein catabolic process can lead to the stabilization of oncoproteins or the loss of tumor suppressors, promoting tumorigenesis. For instance, the Hippo pathway kinases regulate substrate stability, and their dysregulation is linked to cancer. Targeting these regulatory mechanisms is a promising therapeutic strategy.
Metabolic disorders
Altered protein catabolism contributes to metabolic diseases such as obesity and diabetes. AMPK and HSC70 regulate FSP27 stability, which affects lipid droplet formation and energy homeostasis. Negative energy balance also impacts skeletal muscle protein turnover, and dietary protein can modulate these effects. Thus, GO:0042177 is relevant to metabolic research.
Neurodegeneration
Impaired protein degradation is a common feature of neurodegenerative diseases. Negative regulation of protein catabolic process may exacerbate the accumulation of aggregation-prone proteins, such as in Alzheimer's and Parkinson's diseases. Understanding how this process is controlled could reveal new therapeutic targets.
Muscle wasting
In conditions of negative energy balance, such as fasting or cachexia, muscle protein breakdown is accelerated. Negative regulation of protein catabolic process is critical to preserve muscle mass. Research into the regulators of this process may inform interventions for muscle wasting.
From negative regulation of protein catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X negatively regulate protein catabolism? | CRISPR knockout followed by proteomics |
| What is the effect of a specific point mutation in gene Y? | CRISPR point mutation knock-in |
| How does tagging gene Z affect its function? | CRISPR knock-in of epitope tag |
| Does overexpression of gene W stabilize target proteins? | CRISPR overexpression (CRISPRa) |
| Which genes are essential for negative regulation? | Genome-wide CRISPR library screening |
| How does signaling pathway A regulate protein stability? | Knockout of pathway components plus imaging |
How to Study the negative regulation of protein catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Mass spectrometry proteomics | Protein abundance and turnover | Global analysis of degradation |
| Pulse-chase with SILAC | Protein half-lives | Quantifying stabilization effects |
| RNA-seq | Transcriptional changes | Identifying compensatory pathways |
| Fluorescence microscopy | Protein localization and stability | Live-cell imaging of reporters |
| CRISPR knockout screening | Gene essentiality for process | Discovery of novel regulators |
| CRISPR activation (CRISPRa) | Overexpression effects | Gain-of-function studies |
| Co-immunoprecipitation | Protein-protein interactions | Identifying complexes like SCF-Lag2 |
Proteomics and protein turnover assays
Mass spectrometry-based proteomics can quantify global protein degradation rates and identify substrates of negative regulation. Pulse-chase experiments using stable isotope labeling are classic methods to measure protein half-lives.
Transcriptomics and RNA-seq
RNA-seq reveals transcriptional changes that may compensate for or contribute to negative regulation of protein catabolism. It is often used in conjunction with proteomics to distinguish transcriptional from post-transcriptional effects.
Imaging and live-cell reporters
Fluorescent reporters fused to target proteins allow real-time monitoring of protein stability and localization. For example, GFP-tagged FSP27 can be used to track its degradation in response to AMPK activation.
CRISPR-based functional genomics
CRISPR knockout, activation, and interference screens are powerful for identifying regulators of protein catabolic processes. These screens can be coupled with reporters or selection markers to enrich for cells with altered protein stability.
How CRISPR Can Be Used to Study GO:0042177 negative regulation of protein catabolic process
Knockout
CRISPR knockout is used to delete genes suspected to negatively regulate protein catabolic process, such as Lag2 or AMPK, to assess their impact on protein stability. Knockout cell lines can be analyzed by proteomics to identify stabilized proteins.
Point Mutation
Point mutations can be introduced to mimic disease-associated variants or to abrogate specific phosphorylation sites, e.g., in FSP27 or Girdin, to study their role in protein catabolism. This allows precise structure-function analysis.
Knock-in
Knock-in of epitope tags or fluorescent proteins enables tracking of endogenous proteins and their degradation dynamics. For example, tagging FSP27 with GFP allows real-time imaging of its stability.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression is used to elevate levels of negative regulators, such as Lag2 or Maf1, to test their sufficiency in inhibiting protein catabolism. Overexpression models are valuable for gain-of-function studies.
How EDITGENE Supports negative regulation of protein catabolic process Research
Researchers studying negative regulation of protein catabolic process-related genes often need to determine whether a candidate gene is causally involved in stabilizing specific proteins or modulating degradation pathways. This requires precise genetic models that can knockout, mutate, tag, or overexpress the gene of interest in relevant cell types. EDITGENE provides end-to-end CRISPR services to accelerate such discoveries.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of protein catabolic process research.
Frequently Asked Questions About negative regulation of protein catabolic process
What is GO:0042177?
GO:0042177 is the Gene Ontology term for negative regulation of protein catabolic process, defined as any process that stops, prevents, or reduces the frequency, rate, or extent of protein catabolic process.
What genes are involved in negative regulation of protein catabolic process?
Key genes include Lag2, SCF complex components, AMPK, HSC70, 4F2hc/Girdin, and CDK8-AHL10-SUVH2/9 module members.
How is negative regulation of protein catabolic process studied?
It is studied using proteomics, RNA-seq, imaging, and CRISPR-based functional genomics, including knockout, point mutation, knock-in, and overexpression models.
What diseases are associated with GO:0042177?
Dysregulation is linked to cancer, metabolic disorders, neurodegeneration, and muscle wasting.
What is the role of AMPK in protein catabolism?
AMPK regulates FSP27 stability, thereby influencing lipid metabolism and protein catabolic processes.
How does Lag2 regulate protein degradation?
Lag2 interacts with the SCF complex and regulates its function, modulating substrate ubiquitination and degradation.
What is the connection between GO:0042177 and autophagy?
Negative regulation of protein catabolic process can involve inhibition of autophagy, though specific regulators vary by context.
Can CRISPR be used to study negative regulation of protein catabolic process?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression are powerful tools to dissect gene function in this process.
What are the synonyms for GO:0042177?
Synonyms include inhibition of protein catabolic process, down-regulation of protein degradation, and negative regulation of cellular protein breakdown.
Why is negative regulation of protein catabolic process important for cancer research?
It controls the stability of oncoproteins and tumor suppressors; its dysregulation can promote tumorigenesis.
Conclusion
GO:0042177, negative regulation of protein catabolic process, is a critical biological process that maintains protein homeostasis and regulates diverse cellular functions. Its dysregulation is implicated in cancer, metabolic disorders, and neurodegeneration, making it a prime target for therapeutic intervention. Advances in CRISPR-based models and multi-omics approaches are accelerating our understanding of this process. EDITGENE provides comprehensive services to support researchers in dissecting the genes and mechanisms underlying GO:0042177.
References
- 1. Guo P et al.. 2025. Salt stress activates the CDK8-AHL10-SUVH2/9 module to dynamically regulate salt tolerance in Arabidopsis.. Nat Commun 16(1):2454 PMID: 40074748
- 2. Liu Y et al.. 2009. A longevity protein, Lag2, interacts with SCF complex and regulates SCF function.. EMBO J 28(21):3366-77 PMID: 19763088
- 3. Avruch J et al.. 2012. Protein kinases of the Hippo pathway: regulation and substrates.. Semin Cell Dev Biol 23(7):770-84 PMID: 22898666
- 4. Wall E et al.. 2018. The Complex Rcs Regulatory Cascade.. Annu Rev Microbiol 72:111-139 PMID: 29897834
- 5. Weng L et al.. 2018. Negative regulation of amino acid signaling by MAPK-regulated 4F2hc/Girdin complex.. PLoS Biol 16(3):e2005090 PMID: 29538402
- 6. Zhang X et al.. 2014. Regulation of FSP27 protein stability by AMPK and HSC70.. Am J Physiol Endocrinol Metab 307(11):E1047-56 PMID: 25315694
- 7. Carbone JW et al.. 2012. Skeletal muscle responses to negative energy balance: effects of dietary protein.. Adv Nutr 3(2):119-26 PMID: 22516719
- 8. Cieśla M et al.. 2008. Regulation of RNA polymerase III transcription by Maf1 protein.. Acta Biochim Pol 55(2):215-25 PMID: 18560610
